Glaukos Corporation (GKOS)
NYSE: GKOS · IEX Real-Time Price · USD
120.73
+2.02 (1.70%)
At close: Jul 19, 2024, 4:00 PM
120.84
+0.11 (0.09%)
After-hours: Jul 20, 2024, 12:58 PM EDT

Glaukos Revenue

Glaukos had revenue of $326.43M in the twelve months ending March 31, 2024, with 12.92% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $85.62M with 15.86% year-over-year growth. In the year 2023, Glaukos had annual revenue of $314.71M with 11.26% growth.

Revenue (ttm)
$326.43M
Revenue Growth
+12.92%
P/S Ratio
18.63
Revenue / Employee
$359,905
Employees
907
Market Cap
6.08B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023314.71M31.85M11.26%
Dec 31, 2022282.86M-11.15M-3.79%
Dec 31, 2021294.01M69.05M30.70%
Dec 31, 2020224.96M-12.03M-5.07%
Dec 31, 2019236.98M55.71M30.73%
Dec 31, 2018181.28M22.02M13.83%
Dec 31, 2017159.25M44.86M39.21%
Dec 31, 2016114.40M42.70M59.55%
Dec 31, 201571.70M26.11M57.28%
Dec 31, 201445.59M24.64M117.64%
Dec 31, 201320.95M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Grifols 7.32B
Elanco Animal Health 4.37B
Bausch + Lomb 4.31B
Acadia Healthcare Company 2.99B
Masimo 1.98B
Stevanato Group 1.18B
HealthEquity 1.04B
Krystal Biotech 95.95M
Revenue Rankings